David R Pelizzon - Net Worth and Insider Trading

David R Pelizzon Net Worth

The estimated net worth of David R Pelizzon is at least $144 Million dollars as of 2024-04-26. David R Pelizzon is the Director, 10% Owner of Alphatec Holdings Inc and owns about 11,674,290 shares of Alphatec Holdings Inc (ATEC) stock worth over $143 Million. David R Pelizzon is also the Director of OrthoPediatrics Corp and owns about 23,125 shares of OrthoPediatrics Corp (KIDS) stock worth over $692,363. Details can be seen in David R Pelizzon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David R Pelizzon has not made any transactions after 2023-03-13 and currently still holds the listed stock(s).

Transaction Summary of David R Pelizzon

To

David R Pelizzon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David R Pelizzon owns 2 companies in total, including OrthoPediatrics Corp (KIDS) , and Alphatec Holdings Inc (ATEC) .

Click here to see the complete history of David R Pelizzon’s form 4 insider trades.

Insider Ownership Summary of David R Pelizzon

Ticker Comapny Transaction Date Type of Owner
KIDS OrthoPediatrics Corp 2022-08-11 director & 10 percent owner
ATEC Alphatec Holdings Inc 2023-03-13 director & 10 percent owner

David R Pelizzon Latest Holdings Summary

David R Pelizzon currently owns a total of 2 stocks. Among these stocks, David R Pelizzon owns 11,674,290 shares of Alphatec Holdings Inc (ATEC) as of March 13, 2023, with a value of $143 Million and a weighting of 99.52%. David R Pelizzon also owns 23,125 shares of OrthoPediatrics Corp (KIDS) as of November 11, 2021, with a value of $692,363 and a weighting of 0.48%.

Latest Holdings of David R Pelizzon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATEC Alphatec Holdings Inc 2023-03-13 11,674,290 12.24 142,893,310
KIDS OrthoPediatrics Corp 2021-11-11 23,125 29.94 692,363

Holding Weightings of David R Pelizzon


David R Pelizzon Form 4 Trading Tracker

According to the SEC Form 4 filings, David R Pelizzon has made a total of 5 transactions in Alphatec Holdings Inc (ATEC) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Alphatec Holdings Inc is the acquisition of 3,100 shares on March 13, 2023, which cost David R Pelizzon around $47,244.

According to the SEC Form 4 filings, David R Pelizzon has made a total of 2 transactions in OrthoPediatrics Corp (KIDS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in OrthoPediatrics Corp is the acquisition of 825 shares on November 11, 2021, which cost David R Pelizzon around $54,846.

Insider Trading History of David R Pelizzon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David R Pelizzon Trading Performance

GuruFocus tracks the stock performance after each of David R Pelizzon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David R Pelizzon is 8.21%. GuruFocus also compares David R Pelizzon's trading performance to market benchmark return within the same time period. The performance of stocks bought by David R Pelizzon within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David R Pelizzon's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David R Pelizzon

Average Return

19.05%

Average return per transaction

Outperforming Transactions

40%

4 out of 10 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.59 8.21 7 19.05 8.52 14.76
Relative Return to S&P 500(%) 3.24 4.35 4.44 16.16 8.52 3.61

David R Pelizzon Ownership Network

Ownership Network List of David R Pelizzon

No Data

Ownership Network Relation of David R Pelizzon


David R Pelizzon Owned Company Details

What does OrthoPediatrics Corp do?

Who are the key executives at OrthoPediatrics Corp?

David R Pelizzon is the director & 10 percent owner of OrthoPediatrics Corp. Other key executives at OrthoPediatrics Corp include director & President and CEO Mark C Throdahl , director & Chief Financial Officer Fred Hite , and Executive Vice President Gregory A Odle .

OrthoPediatrics Corp (KIDS) Insider Trades Summary

Over the past 18 months, David R Pelizzon made no insider transaction in OrthoPediatrics Corp (KIDS). Other recent insider transactions involving OrthoPediatrics Corp (KIDS) include a net sale of 9,653 shares made by Gregory A Odle , a net sale of 7,551 shares made by Fred Hite , and a net sale of 5,457 shares made by Joseph W Hauser .

In summary, during the past 3 months, insiders sold 17,253 shares of OrthoPediatrics Corp (KIDS) in total and bought 0 shares, with a net sale of 17,253 shares. During the past 18 months, 33,658 shares of OrthoPediatrics Corp (KIDS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,658 shares.

OrthoPediatrics Corp (KIDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

OrthoPediatrics Corp Insider Transactions

No Available Data

David R Pelizzon Mailing Address

Above is the net worth, insider trading, and ownership report for David R Pelizzon. You might contact David R Pelizzon via mailing address: 2850 Frontier Dr, Warsaw In 46582.

Discussions on David R Pelizzon

No discussions yet.